Bicycle Therapeutics PLC (BCYC): Net Income
-$218.96M
Year ended 2025-12-31
-$190.41M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$218.96M | n/m | 2026-03-17, From 2025-01-01 |
| 2024-12-31 | -$169.03M | n/m | 2026-03-17, From 2024-01-01 |
| 2023-12-31 | -$180.66M | n/m | 2026-03-17, From 2023-01-01 |
| 2022-12-31 | -$112.72M | n/m | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | -$66.82M | n/m | 2024-02-20, From 2021-01-01 |
| 2020-12-31 | -$51.01M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$30.61M | n/m | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | -$21.85M | n/m | 2021-03-11, From 2018-01-01 |
| 2017-12-31 | -$16.26M | n/a | 2020-03-10, From 2017-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | -$218.96M | n/m |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | -$6.12M | n/m |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | -$342.60M | n/m |
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | -$146.41M | n/m |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | -$5.31M | n/m |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | -$17.37M | n/m |
| Kura Oncology, Inc. (KURA) | 2025-12-31 | -$278.67M | n/m |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $8.57M | n/m |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | -$4.60M | n/m |
Compare BCYC, ASMB, VRDN, ABCL side by side · Screen every company in Pharmaceutical Preparations ↗